Proteome Sciences. AGM Statement.

TD - wouldn't that be insider trading? though it would seem the wrong way round, since any settlement (according to this BB) would send PRM shares soaring. More likely that SA are disposing of a few holdings to make way for :

LONDON (MarketWatch) -- Sanofi-Aventis (SNY) : would like to buy a biotech if one was available, CEO Jean-Francois Dehecq told the La Tribune newspaper in an interview. The company would considering buying one with three or four products, even if it was a complicated and costly move.